AGTC to Present at Cell & Gene Meeting on the Mediterranean
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical stage...
BOTHELL, Wash., April 14, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, Chief Financial Officer and...
BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused...
SAN DIEGO and CAMBRIDGE, United Kingdom, April 14, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX) and Mundipharma today...
SAN DIEGO, April 14, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today...
OREM, Utah, April 14, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
LOS ANGELES, April 14, 2022 (GLOBE NEWSWIRE) -- Sera Labs, a wholly subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR),...
Company Announcement, Helsinki, 14 April 2022 at 2:50 PM (EEST) Nexstim Plc: Managers’ Transactions, Weckroth Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim"...
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the...
Company Announcement, Helsinki, 14 April 2022 at 2:40 PM (EEST) Nexstim Plc: Managers’ Transactions, Forss Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim"...
Company Announcement, Helsinki, 14 April 2022 at 2:30 PM (EEST) Nexstim Plc: Managers’ Transactions, Niemistö Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim"...
29% increase in Twirla cycles27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) --...
Milestone and Keystone Dental Group Form Strategic Channel Partnershipto Expand the STA Single Tooth Anesthesia® System within Implant Dentistry Milestone...
Randomized Phase 2 clinical study evaluating SRF388 in first-line hepatocellular carcinoma in clinical collaboration with Roche Single-arm Phase 2 clinical...
Gilmore O’Neill Editas Medicine today announced that its Board of Directors has appointed Dr. Gilmore O’Neill, M.B., M.M.Sc., as President...
New Collaboration to Expand the STA Single Tooth Anesthesia® System within Implant DentistryBURLINGTON, Mass., April 14, 2022 (GLOBE NEWSWIRE) --...
Company is in its strongest financial position ever, having raised $8 million in 16 monthsANN ARBOR, Mich., April 14, 2022...
- Company to host call today, April 14, 2022 at 8:00 am ET - Conference call can be accessed by...
AUDUBON, Pa.--(BUSINESS WIRE)--AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy products that treat lymphedema and...
DUBLIN--(BUSINESS WIRE)--The "US Digital Health Market (by Technology & Component): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report...